drugset / Trial / NCT01972724
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy of pioglitazone 30 mg on glycemic control when used in participants with inadequately controlled type 2 diabetes mellitus treated with stable combinations of metformin and sulfonylurea.
Timeline
- Start
- 2013-12-16
- Primary completion
- 2016-10-17
- Completion
- 2016-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 15 mg | Oral |
| Subject | Pioglitazone | Small molecule | 30 mg | Oral |
| Background | Glimepiride | Small molecule | — | — |
| Background | Metformin | Small molecule | — | — |